Related Experiment Videos

[The mechanisms of morphine dependence and it's withdrawal syndrome: study in mutant mice]

Y Noda1, T Mamiya, T Nabeshima

  • 1Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, 65, Tsuruma-cho, Showaku, Nagoya 466-8560, Japan. y-noda@med.nagoya-u.ac.jp

Insights

Catecholamines and cAMP response element binding protein (CREB) binding protein (CBP) are crucial for developing morphine dependence. Genetic alterations in these systems prevent morphine-induced preference and withdrawal symptoms in mice.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Context:

  • Drug dependence, particularly morphine addiction, is a significant public health concern.
  • The roles of catecholamines and cyclic AMP (cAMP) signaling pathways in addiction development are not fully understood.
  • Investigating genetic factors influencing these pathways can reveal mechanisms of drug dependence.

Purpose:

  • To determine the involvement of catecholamines and cAMP systems in morphine dependence.
  • To examine if reduced levels of tyrosine hydroxylase (TH) or cAMP response element binding protein (CREB) binding protein (CBP) affect morphine-induced place preference and withdrawal symptoms in mice.

Summary:

  • Wild-type mice exhibited morphine-induced place preference, while TH+/- and CBP+/- mice did not.
  • Wild-type mice showed withdrawal symptoms (jumping, rearing, tremor) and increased thalamus/hypothalamus cAMP levels after chronic morphine exposure and naloxone challenge.
  • TH+/- and CBP+/- mice displayed reduced withdrawal symptoms, and TH+/- mice showed no increase in cAMP levels, suggesting catecholamines and CBP are vital for morphine dependence.

Impact:

  • This study highlights the critical roles of catecholamines and CBP in the neurobiological mechanisms underlying morphine addiction.
  • Findings suggest that targeting catecholaminergic and/or cAMP signaling pathways could be a potential therapeutic strategy for treating opioid dependence.
  • The research provides a genetic basis for understanding individual susceptibility to drug dependence.

Related Concept Videos